CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas

Refractory (planetary science)
DOI: 10.1016/j.jid.2023.02.011 Publication Date: 2023-03-16T13:28:55Z